Constance Lamy

ORCID: 0000-0003-0311-8031
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Hypoxia, and Metabolism
  • Adrenal and Paraganglionic Tumors
  • Neuroblastoma Research and Treatments
  • Hormonal Regulation and Hypertension
  • Pituitary Gland Disorders and Treatments
  • Chromosomal and Genetic Variations
  • Immune cells in cancer
  • Mitochondrial Function and Pathology
  • vaccines and immunoinformatics approaches
  • Cancer Genomics and Diagnostics
  • Lung Cancer Research Studies
  • Autophagy in Disease and Therapy
  • Phagocytosis and Immune Regulation
  • Neuroendocrine Tumor Research Advances
  • Ubiquitin and proteasome pathways
  • Metabolomics and Mass Spectrometry Studies

Université Paris-Saclay
2021-2024

Institut Gustave Roussy
2019-2024

Inserm
2020-2024

Institut Curie
2024

Radiothérapie Moléculaire et Innovation Thérapeutique
2021

<div>AbstractPurpose:<p>The detection of ctDNA, which allows noninvasive tumor molecular profiling and disease follow-up, promises optimal individualized management patients with cancer. However, detecting small fractions DNA released when the burden is reduced remains a challenge.</p>Experimental Design:<p>We implemented new, highly sensitive strategy to detect bp resolution methylation patterns from plasma assessed potential hypomethylation long interspersed nuclear...

10.1158/1078-0432.c.7747611 preprint EN 2025-04-01

Abstract Context Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that frequently associated with succinate dehydrogenase (SDH) germline mutations. When mutated, SDH losses its function, thus leading to accumulation. Objective In this study, we evaluated serum levels as a new metabolic biomarker in SDHx-related carriers. Methods Retrospective monocentric study of 88 PPGL patients (43 sporadic, 35 SDHB, 10 SDHA/C/D), 17 tumor-free familial asymptomatic carriers (13 4...

10.1210/clinem/dgac474 article EN other-oa The Journal of Clinical Endocrinology & Metabolism 2022-08-10

Abstract Background Tumor-associated macrophages (TAMs) are essential components of the inflammatory microenvironment tumors and associated with poor clinical outcomes in majority cancers. TAMs mainly exhibit anti-inflammatory functions that promote support tissue remodeling, immune suppression tumor growth. Regarding their plasticity, functional reprogramming into proinflammatory phenotype recently emerged as a therapeutic opportunity to improve effectiveness anticancer treatments such...

10.1101/2024.01.12.575217 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-01-15
Coming Soon ...